Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD

Keyphrases

• 2 Receptor 20%
• Acid Hydrolase 20%
• Anhedonia 20%
• Anxiety-like Behavior 20%
• Brain-derived Neurotrophic Factor 100%
• Cannabinoids 100%
• Comorbid 20%
• Depressive 20%
• Depressive-like Behavior 100%
• Endocannabinoid System 20%
• Factor Level 60%
• Fatty Acids 20%
• Fear Circuit 20%
• Fear Extinction 20%
• Fear Retrieval 20%
• Hippocampus 20%
• Hydrolase Inhibitors 20%
• Locomotion 20%
• Neurotrophic Factor Expression 100%
• Passive Coping 20%
• Posttraumatic Stress Disorder 100%
• Prefrontal Cortex 20%
• Rat Model 100%
• Receptor Agonist 20%
• Severe Stress 20%
• Shock 60%
• Social Recognition Memory 20%
• Startle Response 20%
• URB597 20%
• WIN55,212-2 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Acid Hydrolase 20%
• Brain Derived Neurotrophic Factor 100%
• Cannabinoid 100%
• Disease 20%
• Endocannabinoid System 20%
• Fatty Acid 20%
• Hydrolase Inhibitor 20%
• Neurotrophic Factor Expression 100%
• Posttraumatic Stress Disorder 100%
• Rat Model 100%
• Receptor Agonist 20%
• Symptom 100%
• URB597 20%

Neuroscience

• Acid Hydrolase 20%
• Anhedonia 20%
• Behavior (Neuroscience) 40%
• Brain-Derived Neurotrophic Factor 100%
• Cannabinoid 100%
• Endocannabinoid System 20%
• Fatty Acids 20%
• Hippocampus 20%
• Hydrolase Inhibitor 20%
• Locomotion 20%
• Neurotrophic Factor Expression 100%
• Posttraumatic Stress Disorder 100%
• Prefrontal Cortex 20%
• Receptor Agonists 20%
• Recognition Memory 20%
• Startle Response 20%
• URB597 20%